Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.

NCT07668219 is registered in ClinicalTrials.gov with Hospital Universitario San Ignacio as lead sponsor.

NCT NCT07668219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Use of Real-time Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes and Stage 3 and 4 Chronic Kidney Disease.
Lead sponsor
Hospital Universitario San Ignacio
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
May 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cgm, kidney disease, time in range, type 2 diabetes